Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

NASDAQ:DNUT - Nasdaq - US50101L1061 - Common Stock - Currency: USD

4.33  -0.03 (-0.69%)

After market: 4.3399 +0.01 (+0.23%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DNUT. DNUT was compared to 136 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of DNUT have multiple concerns. DNUT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DNUT was profitable.
In the past year DNUT had a positive cash flow from operations.
DNUT had negative earnings in 4 of the past 5 years.
DNUT had a positive operating cash flow in each of the past 5 years.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

DNUT has a Return On Assets of 0.10%. This is in the lower half of the industry: DNUT underperforms 62.50% of its industry peers.
DNUT has a Return On Equity (0.27%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.1%
ROE 0.27%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

DNUT's Profit Margin of 0.19% is on the low side compared to the rest of the industry. DNUT is outperformed by 62.50% of its industry peers.
The Gross Margin of DNUT (32.34%) is worse than 73.53% of its industry peers.
DNUT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.19%
GM 32.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DNUT has more shares outstanding than it did 1 year ago.
DNUT has more shares outstanding than it did 5 years ago.
DNUT has a worse debt/assets ratio than last year.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DNUT has an Altman-Z score of 0.50. This is a bad value and indicates that DNUT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DNUT (0.50) is worse than 79.41% of its industry peers.
DNUT has a Debt/Equity ratio of 0.74. This is a neutral value indicating DNUT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.74, DNUT is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACCN/A
WACC8.05%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.36 indicates that DNUT may have some problems paying its short term obligations.
The Current ratio of DNUT (0.36) is worse than 82.35% of its industry peers.
DNUT has a Quick Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DNUT (0.30) is worse than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.3
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for DNUT have decreased strongly by -57.14% in the last year.
The Revenue has decreased by -1.23% in the past year.
DNUT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.66% yearly.
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.89%
Revenue 1Y (TTM)-1.23%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-10.4%

3.2 Future

DNUT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.74% yearly.
The Revenue is expected to grow by 1.04% on average over the next years.
EPS Next Y-25.29%
EPS Next 2Y44.9%
EPS Next 3Y51.74%
EPS Next 5YN/A
Revenue Next Year-2.75%
Revenue Next 2Y3.37%
Revenue Next 3Y1.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.08, DNUT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as DNUT.
Compared to an average S&P500 Price/Earnings ratio of 23.99, DNUT is valued quite expensively.
With a Price/Forward Earnings ratio of 48.30, DNUT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as DNUT.
DNUT is valuated expensively when we compare the Price/Forward Earnings ratio to 20.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 36.08
Fwd PE 48.3
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DNUT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.36
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5

4.3 Compensation for Growth

A more expensive valuation may be justified as DNUT's earnings are expected to grow with 51.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.9%
EPS Next 3Y51.74%

More info and screens

4

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 3.32%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of DNUT has falen by -49.77%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 3.65, DNUT pays a better dividend. On top of this DNUT pays more dividend than 86.76% of the companies listed in the same industry.
DNUT's Dividend Yield is a higher than the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 3.32%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

765.49% of the earnings are spent on dividend by DNUT. This is not a sustainable payout ratio.
DP765.49%
EPS Next 2Y44.9%
EPS Next 3Y51.74%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
DNUT Dividend Payout.DNUT Dividend Payout, showing the Payout Ratio.DNUT Dividend Payout.PayoutRetained Earnings

More info and screens

KRISPY KREME INC

NASDAQ:DNUT (5/7/2025, 8:00:02 PM)

After market: 4.3399 +0.01 (+0.23%)

4.33

-0.03 (-0.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners62.51%
Inst Owner Change0.05%
Ins Owners3.86%
Ins Owner Change0.05%
Market Cap738.96M
Analysts76
Price Target10.82 (149.88%)
Short Float %29.96%
Short Ratio5.68
Dividend
Industry RankSector Rank
Dividend Yield 3.32%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP765.49%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-23 2025-04-23 (0.035)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-141.05%
Min EPS beat(2)-192.23%
Max EPS beat(2)-89.88%
EPS beat(4)1
Avg EPS beat(4)-69.11%
Min EPS beat(4)-192.23%
Max EPS beat(4)7.96%
EPS beat(8)3
Avg EPS beat(8)-41.27%
EPS beat(12)5
Avg EPS beat(12)-29.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.37%
Min Revenue beat(2)-4.66%
Max Revenue beat(2)-2.08%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.13%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.46%
PT rev (3m)-27.12%
EPS NQ rev (1m)-9.95%
EPS NQ rev (3m)-209.95%
EPS NY rev (1m)-1.25%
EPS NY rev (3m)-70.76%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)-8.64%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-7.88%
Valuation
Industry RankSector Rank
PE 36.08
Fwd PE 48.3
P/S 0.44
P/FCF N/A
P/OCF 16.12
P/B 0.65
P/tB N/A
EV/EBITDA 13.36
EPS(TTM)0.12
EY2.77%
EPS(NY)0.09
Fwd EY2.07%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.27
OCFY6.2%
SpS9.76
BVpS6.65
TBVpS-4.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.1%
ROE 0.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.19%
GM 32.34%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Debt/EBITDA 6.98
Cap/Depr 90.42%
Cap/Sales 7.25%
Interest Coverage N/A
Cash Conversion 37.88%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.3
Altman-Z 0.5
F-Score7
WACC8.05%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.89%
EPS Next Y-25.29%
EPS Next 2Y44.9%
EPS Next 3Y51.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.23%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-10.4%
Revenue Next Year-2.75%
Revenue Next 2Y3.37%
Revenue Next 3Y1.04%
Revenue Next 5YN/A
EBIT growth 1Y-423.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year753.48%
EBIT Next 3Y128.41%
EBIT Next 5YN/A
FCF growth 1Y1.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.63%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%